APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast

• Published in: Proceedings of the National Academy of Sciences - PNAS Vol. 102; no. 28; pp. 9854 - 9859
• Main Authors: Schumacher, A.J, Nissley, D.V, Harris, R.S
• Format: Journal Article
• Language: English
• Published: United States National Academy of Sciences 12-07-2005; National Acad Sciences
• Subjects: Amino Acid Transport Systems, Basic - genetics; APOBEC-3G Deaminase; Biological Sciences; Canavanine - metabolism; Complementary DNA; Cytidine Deaminase; cytosine; Cytosine - metabolism; deamination; Deoxyribonucleic acid; DNA; DNA Primers; Enzymes; Genetic mutation; Genetic vectors; Genomics; HIV 1; Humans; hypermutation; Immunoblotting; Lesions; Mutagenesis; Mutation; Mutation - genetics; Nucleoside Deaminases; Proteins - metabolism; Repressor Proteins; Retroelements - genetics; retrotransposition; Retrotransposons; Retroviridae; Saccharomyces cerevisiae; Saccharomyces cerevisiae - genetics; Saccharomyces cerevisiae Proteins - genetics; Sequence Analysis, DNA; transposition (genetics); Yeast; Yeasts
• ISSN: 0027-8424; 1091-6490
• DOI: 10.1073/pnas.0501694102

Human cells harbor a variety of factors that function to block the proliferation of foreign nucleic acid. The APOBEC3G enzyme inhibits the replication of retroviruses by deaminating nascent retroviral cDNA cytosines to uracils, lesions that can result in lethal levels of hypermutation. Here, we demonstrate that APOBEC3G is capable of deaminating genomic cytosines in Saccharomyces cerevisiae. APOBEC3G expression caused a 20-fold increase in frequency of mutation to canavanine-resistance, which was further elevated in a uracil DNA glycosylase-deficient background. All APOBEC3G-induced base substitution mutations mapped to the nuclear CAN1 gene and were exclusively C/G to T/A transition mutations within a 5'-CC consensus. The APOBEC3G preferred sites were found on both strands of the DNA duplex, but were otherwise located in hotspots nearly identical to those found previously in retroviral cDNA. This unique genetic system further enabled us to show that expression of APOBEC3G or its homolog APOBEC3F was able to inhibit the mobility of the retrotransposon Ty1 by a mechanism that involves the deamination of cDNA cytosines. Thus, these data expand the range of likely APOBEC3 targets to include nuclear DNA and endogenous retroelements, which have pathological and physiological implications, respectively. We postulate that the APOBEC3-dependent innate cellular defense constitutes a tightly regulated arm of a conserved mobile nucleic acid restriction mechanism that is poised to limit internal as well as external assaults.